On barring the vascular gateway against severe COVID-19 disease

Cell Stress Chaperones. 2020 Sep;25(5):721-723. doi: 10.1007/s12192-020-01122-z.

Authors

George Perdrizet¹, Lawrence E Hightower²

Affiliations

¹ Advanced Wound Care and Hyperbaric Medicine, The Hospital of Central Connecticut, 5 Highland Street, New Britain, CT, 06052, USA.
² Department of Molecular and Cell Biology, University of Connecticut, Storrs, CT, 06269, USA. Lawrence.hightower@uconn.edu.

No abstract available

Publication types

Letter

MeSH terms

Animals
COVID-19
Coronavirus Infections* / immunology
Coronavirus Infections* / therapy
HSP70 Heat-Shock Proteins / immunology*
Humans
Hyperbaric Oxygenation / methods*
Pandemics*
Pneumonia, Viral* / immunology
Pneumonia, Viral* / therapy
Rats, Wistar
Tin Compounds / therapeutic use*

Substances

HSP70 Heat-Shock Proteins
HSPA1A protein, human
Tin Compounds
stannous chloride